More articles about: Urology
Health Lab
Urine-based test detects aggressive prostate cancer
Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit.
Health Lab
How donor eggs helped one couple build the family they always hoped for
After learning her chances with her own eggs were low, a Michigan mom turned to donor egg IVF at the U-M Health Center for Reproductive Medicine.
Health Lab
What causes infertility? A doctor answers common questions and clears up misconceptions
For fertility, timing and age to stress and lifestyle all play a factor. Here, a Michigan Medicine fertility doctor explains what impacts your chances of getting pregnant and when to get help.
Philanthropy News
Ippolito family celebrates milestone and a transatlantic legacy
Giulia Ippolito, M.D., and her siblings have created a fund to honor the 50th anniversary of their parents and promote urology learning partnerships between the U-M Medical School and the University of Palermo in Italy.
Health Lab
Insurance that covers male infertility procedures improves opportunities for family building
President Donald Trump recently signed an executive order dedicated to improving and expanding in vitro fertilization care for couples across the United States. A new paper published by the University of Michigan finds that including male infertility care in health insurance coverage mandates is associated with more births; this one was to assist couples having trouble to conceive.
Health Lab
IVF insurance coverage varies greatly among larger employers
Study from Michigan Medicine find that details of insurance coverage for IVF vary greatly among larger, self-insured employers, making insurance coverage challenging to follow for a wider, country-wide roll out.
Health Lab
Model predicts long term mortality risk from prostate cancer
Existing risk calculators for prostate cancer have less accurate estimates or predict risk through tests based on biopsy, which requires tissue samples and extra processing times. U-M researchers have developed a new model that can help doctors and patients understand their PSA results and what it means for patient life expectancy.
Health Lab
Should you get a vasectomy?
Learn more about vasectomies from leading experts in the field of urology at Michigan Medicine.
Health Lab
Examining private equity’s role in fertility care
The percentage of fertility clinics affiliated with private equity firms rose in the past decade, and half of all IVF cycles now occur at such clinics.
Cancer Aware
Understanding Prostate Biopsy
Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.
Health Lab Podcast
Vasectomy FAQ
Today on Health Lab we're bringing you something a little bit different - an expert FAQ with a U-M Health urologist answering common questions about vasectomies.
Health Lab
Study identifies key features of cancer cell response and resistance to treatment
University of Michigan researchers created a prostate cancer cellular atlas, identifying why some prostate tumor cells resist therapy and others respond to treatments.
Health Lab
Testicular cancer patient encourages others
Zach Hiser, a testicular cancer patient, encourages fellow fans to get help if they have symptoms.
Health Lab
Active surveillance helps men avoid unnecessary surgery for prostate cancer
About one in eight men in the United States are diagnosed with prostate cancer during their lifetime. However, each man’s risk can vary based on age, race, family history and lifestyle. Todd Morgan answers questions about the different stages of prostate cancer, when active surveillance is preferred and why surgical interventions can be harmful.
Health Lab
Inactivation of key pathway boosts the body’s immune response against tumors
Immunotherapy uses the body’s immune system to recognize and destroy cancer cells. However, many patients are resistant to this therapy, which poses a challenge to their treatment. A study led by researchers from the University of Michigan showed that targeting CDK12/13 improves the effectiveness of cancer therapies.